COMMONWEALTH EQUITY SERVICES, LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$649,000
-6.6%
6,984
-40.2%
0.00%
-50.0%
Q3 2021$695,000
-11.8%
11,680
+1.1%
0.00%0.0%
Q2 2021$788,000
-2.5%
11,556
-0.9%
0.00%0.0%
Q1 2021$808,000
-12.1%
11,656
-2.6%
0.00%
-33.3%
Q4 2020$919,000
+15.0%
11,971
+12.0%
0.00%0.0%
Q3 2020$799,000
+37.8%
10,688
+15.9%
0.00%
+50.0%
Q2 2020$580,000
+83.0%
9,218
+21.8%
0.00%
+100.0%
Q1 2020$317,000
+18.3%
7,568
+28.1%
0.00%0.0%
Q4 2019$268,000
-0.4%
5,908
+0.2%
0.00%0.0%
Q3 2019$269,000
-31.4%
5,897
-11.9%
0.00%
-50.0%
Q2 2019$392,000
+41.5%
6,693
+8.3%
0.00%
+100.0%
Q1 2019$277,000
+22.0%
6,182
+5.6%
0.00%0.0%
Q4 2018$227,000
-15.6%
5,8520.0%0.00%0.0%
Q3 2018$269,000
+15.0%
5,852
+9.3%
0.00%0.0%
Q2 2018$234,000
+4.0%
5,356
-6.2%
0.00%0.0%
Q1 2018$225,0005,7070.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Prosight Management, LP 252,500$11,320,0004.95%
Rubric Capital Management LP 857,103$38,424,0003.59%
PFM Health Sciences, LP 3,255,230$145,932,0003.22%
Partner Investment Management, L.P. 40,605$1,820,0002.10%
DAFNA Capital Management LLC 93,942$4,211,0001.82%
Atika Capital Management LLC 195,000$8,742,0001.78%
Perceptive Advisors 1,400,171$62,770,0001.77%
EMORY UNIVERSITY 47,779$2,142,0001.51%
Rhenman & Partners Asset Management AB 234,558$10,515,0001.23%
Eversept Partners, LP 75,721$3,394,5720.99%
View complete list of ARENA PHARMACEUTICALS INC shareholders